Table 3.
Predictor Variables | Hazard Ratio (HR) | 95% CI of HR | p Value | |
---|---|---|---|---|
Lower | Upper | |||
Gender | ||||
Male | 1 | |||
Female | 2.100 | 1.270 | 3.470 | 0.004 |
ECOG | ||||
0 | 1 | |||
1/2 | 1.168 | 0.649 | 2.101 | 0.604 |
3 | 2.922 | 1.363 | 6.265 | 0.006 |
Platelet/lymphocyte ratio | ||||
≤270 | 1 | |||
>270 | 1.687 | 1.051 | 2.710 | 0.030 |
Sarcopenia | ||||
Yes | 2.333 | 1.251 | 4.349 | 0.008 |
No | 1 | |||
Metastatic site | ||||
Non-liver | 1 | |||
Liver | 2.241 | 1.369 | 3.671 | 0.001 |
Sunitinib dose (mg) | ||||
25 | 2.205 | 0.809 | 6.008 | 0.122 |
37.5 | 2.437 | 1.011 | 5.872 | 0.047 |
50 | 1 | |||
Hypertension | ||||
No | 2.361 | 1.331 | 4.186 | 0.003 |
Yes | 1 | |||
Hand–foot syndrome | ||||
No | 2.995 | 1.835 | 4.888 | <0.0001 |
Yes | 1 |